.png?width=480&height=600&func=crop&&gravity=smart)
Across Europe, knowledge transfer offices are increasingly encouraged to adopt “startup-friendly” deal terms, often benchmarked against US models. But what does that actually mean in practice? Founders and investors frequently claim that US spinouts receive better deals, but is this really the case? And if so, which specific terms make the difference?
In this 60-minute Spinout SIG webinar, a US knowledge transfer leader will open with a short presentation outlining the most important clauses in a typical single-patent spinout deal. These include equity percentage, royalty rates, anti-dilution provisions, shareholder blocking rights, and lab cost arrangements. The presentation will also explain the rationale behind these structures and how US KTOs manage pushback from investors and founders.
Following this, European tech transfer professionals from the UK and continental Europe will reflect on the practical realities that shape deal terms within their institutions.
Together, the panel will explore whether the European definition of “startup-friendly” differs meaningfully from the US one, and if so, where and why these differences arise.
This webinar is organised by the Spin-off SIG. Join the Spin-off SIG to stay tuned.
The expert-panel discussion educated me in strategic and meritorious choice of inventions to approach investors and manage investment funds for establishing a spin off.
Ram Siddappa
Erasmus MC, Netherlands
There was ample opportunity to learn from colleagues through the workshop sessions or more formally through speakers either sharing their years of experience or their state of the art research. Well worth attending.
John Gleeson
University of Limerick, Ireland
I really like the course and the networking. I would like to come again.
Nancy Goel
Qatar Foundation, Qatar
A lot of fruitful discussions with experienced peers. Very helpful sessions.
Sara Matt-Leubner
University of Innsbruck, Austria
This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.
Ram Siddappa
Erasmus MC, Netherlands
Join our newsletter and get the latest news